Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination. Continue your routine care with us by scheduling an in-person appointment or Video Visit.

Warning message

The subscription service is currently unavailable. Please try again later.


Pancreatic cancer cells find unique fuel sources to keep from starving

Wednesday, August 10, 2016

Photo of Costas LyssiotisCostas Lyssiotis Pancreatic cancer cells avert starvation in dense tumors by ordering nearby support cells to supply them with an alternative source of nutrition. This is the finding of a study in cancer cells and mice published August 10 in Nature.

Led by researchers from NYU Langone Medical Center and the Dana Farber Cancer Institute at Harvard, the study also involved Meyer director Lewis Cantley, Ph.D., and former Cantley Lab postdoc Costas Lyssiotis, Ph.D., now at the Department of Molecular and Integrative Physiology at the University of Michigan Medical School.

The results revolve around the unique ability of pancreatic cancers to scavenge for energy when oxygen and blood sugar (glucose), normally supplied by the bloodstream, are in short supply. This is the case inside tumors where abnormal cell growth quickly consumes available resources.

The current study is the first to reveal that pancreatic cancer cells send signals to stellate cells (a type of cell in the pancreatic environment that can secrete substances that provide structural support), causing them to break down their own cell parts into various building blocks, including the amino acid alanine. Cancer cells then take up the alanine into their cell powerhouses, called mitochondria, and use it as a fuel source in place of glucose.

"Our study offers more proof that pancreatic cancers not only use fuel differently, but also scavenge for it far more effectively than many cancer types," says corresponding author Alec Kimmelman, M.D., Ph.D., chair of the Department of Radiation Oncology in the Laura and Isaac Perlmutter Cancer Center at NYU Langone.

"This work establishes the existence of a new kind of crosstalk between tumors and stellate cells," says Kimmelman. "Knowing this may help the field to design drugs that interfere with the astonishing metabolic flexibility that makes these cancers unique."

Faced with Starvation

Given that pancreatic cancer cells continue to grow in a low-nutrient environment, the research team sought to determine if the stellate cells could provide fuel to the tumor cells. Experiments indicated that, indeed, stellate cells were secreting metabolites that were causing a 20 to 40 percent increase in mitochondrial metabolism in cancer cells, and an uptick in cancer cell growth. The team next sought to determine which secreted metabolites were taken up by cancer cells to promote the increased mitochondrial metabolism. Of the approximately 200 metabolites analyzed, only the amino acids alanine and aspartate fit this pattern, and only alanine significantly increased mitochondrial metabolism and tumor cell proliferation.

The team next sought to determine how the cancer cells were using the alanine. Studies that tagged the carbon molecules comprising alanine confirmed that pancreatic adenocarcinoma cells convert alanine into related metabolites and feed it into the tricarboxylic acid (TCA) cycle, the series of reactions making up the first part of energy production in mitochondria. Importantly, by using the alanine, the tumor cells could divert glucose to other critical pathways, such as those making the building blocks for DNA.

Furthermore, the team found that cancer cells, by secreting some still unknown factor, signal for stellate cells to provide more alanine by turning up a process called autophagy. Basic to cellular life, autophagy envelopes damaged cell parts into vesicles, like mini cells that home to and fuse with lysosomes. These pockets in turn break down proteins and fats into metabolites, which are recycled to build new DNA strands and membranes. Cancer cells cannot multiply without these building blocks on hand.

The group then tested the importance of this metabolic cross-talk in terms of tumor growth in mice. Because alanine secretion by the stellate cells was dependent on autophagy, researchers could selectively disrupt it using genetic techniques in the stellate cells of mice with cancer. Tumor growth was largely blocked in mice with stellate cells where autophagy was inhibited.

Related Stories

Pancreas and colon tumors reprogram the liver, causing wasting and short-circuiting body's immune response

Does radiotherapy in unresectable pancreatic cancer add value?

The cancer campaign that got personal

A pancreatic cancer community that crowdsources new treatments

"Let's Win" aims to reduce research burden for those with pancreatic cancer

Back in the saddle

Addition of capecitabine to adjuvant chemotherapy extends survival in pancreatic cancer

Precision medicine, genomics to speed cures for disease

Immunotherapy research in pancreatic cancer given $1m boost

Study Discovers How Pancreatic Cancer Spreads to the Liver

Protein critical to cell survival also promotes metastasis independently

Tumor exosome protein signatures predict future organ sites of cancer spread

Uncovering new functions of a gene implicated in cancer growth opens new therapeutic possibilities

21 completely reassuring things scientists wish you knew about cancer

Cantley team uncovers vulnerability that can be exploited to kill lung cancer cells

Metabolic protein linked to cancer and autoimmunity

An old idea, revived: Starve cancer to death

Scientists find link between cancer metabolism and cellular architecture

Vitamin C halts growth of aggressive forms of colorectal cancer in preclinical study

Inhibiting the PI3K Pathway

A Different Prescription: Seeking Progress in Women’s Cancers

Pioneering Personalized Medicine

Bench to Bedside

Leading cancer scientist & entrepreneur on research in NY

Pathway to collaboration

Cantley, Rubin among "most influential scientific minds"